ATE420664T1 - Mittel für magnetisches bildformungsverfahren - Google Patents

Mittel für magnetisches bildformungsverfahren

Info

Publication number
ATE420664T1
ATE420664T1 AT03735518T AT03735518T ATE420664T1 AT E420664 T1 ATE420664 T1 AT E420664T1 AT 03735518 T AT03735518 T AT 03735518T AT 03735518 T AT03735518 T AT 03735518T AT E420664 T1 ATE420664 T1 AT E420664T1
Authority
AT
Austria
Prior art keywords
integer
tumor
mri detectable
agent
image forming
Prior art date
Application number
AT03735518T
Other languages
English (en)
Inventor
S Aime
V Mainero
Chrich S Geninatti
C Cabella
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Application granted granted Critical
Publication of ATE420664T1 publication Critical patent/ATE420664T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Soft Magnetic Materials (AREA)
  • Magnetic Record Carriers (AREA)
  • Measuring Magnetic Variables (AREA)
AT03735518T 2002-06-05 2003-06-02 Mittel für magnetisches bildformungsverfahren ATE420664T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02012531A EP1369134A1 (de) 2002-06-05 2002-06-05 Mittel fur magnetisches Bildformungsverfahren

Publications (1)

Publication Number Publication Date
ATE420664T1 true ATE420664T1 (de) 2009-01-15

Family

ID=29433117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03735518T ATE420664T1 (de) 2002-06-05 2003-06-02 Mittel für magnetisches bildformungsverfahren

Country Status (7)

Country Link
US (2) US7780952B2 (de)
EP (2) EP1369134A1 (de)
JP (1) JP4469273B2 (de)
AT (1) ATE420664T1 (de)
AU (1) AU2003238192A1 (de)
DE (1) DE60325849D1 (de)
WO (1) WO2003103722A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1369134A1 (de) * 2002-06-05 2003-12-10 Bracco Imaging S.p.A. Mittel fur magnetisches Bildformungsverfahren
JP2004307356A (ja) * 2003-04-02 2004-11-04 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 新規なデンドリマーおよび造影剤
WO2006027244A2 (en) * 2004-09-10 2006-03-16 Bracco Imaging S.P.A. Paramagnetic metal polyamino complexes for mri visualization of internalized polynucleotides
WO2006037124A2 (en) * 2004-09-28 2006-04-06 Mallinckrodt Inc. Container with constrained quality maintenance agent
WO2006095745A1 (ja) * 2005-03-07 2006-09-14 National University Corporation Shizuoka University ジエチレントリアミン五酢酸誘導体、ガドリニウム－ジエチレントリアミン五酢酸誘導体の錯体及びｍｒｉ造影剤並びに富血性腫瘍特異性造影剤
WO2007142804A2 (en) * 2006-06-01 2007-12-13 Mallinckrodt Inc. Preparation of complexing agents and metal ion complexes in aqueous media
JPWO2008044443A1 (ja) * 2006-10-06 2010-02-04 国立大学法人静岡大学 ガドリニウム化合物及びｍｒｉ用造影剤
US7875747B2 (en) * 2006-10-10 2011-01-25 Afton Chemical Corporation Branched succinimide dispersant compounds and methods of making the compounds
CN100560138C (zh) * 2007-02-02 2009-11-18 厦门大学 一种核磁共振成像造影剂及其制备方法
KR101098136B1 (ko) 2009-09-02 2011-12-26 경북대학교 산학협력단 높은 자기 이완율을 가지는 상자성 다핵금속착물, 이의 제조방법 및 이를 포함하는 조영제
WO2011133115A1 (en) * 2010-04-22 2011-10-27 Singapore Health Services Pte. Ltd. Tumour radiolabelling imaging agents comprising ornithine and derivatives thereof
FR2986332A1 (fr) * 2012-01-30 2013-08-02 Centre Nat Rech Scient Nanoparticules a luminescence persistante pour l'imagerie optique en temps reel, l'imagerie multimodale optique-irm in vivo, et la theranostique
WO2013134342A1 (en) * 2012-03-09 2013-09-12 New York University Methods and kits for detecting non-luminescent or weakly luminescent metals
FR3046172B1 (fr) * 2015-12-24 2019-05-31 Guerbet Ligands macrocycliques avec groupement(s) picolinate(s), leurs complexes ainsi que leurs utilisations medicales
CN108779082B (zh) * 2016-04-13 2022-08-02 伯拉考成像股份公司 造影剂
CN115894301B (zh) * 2022-10-25 2024-08-13 武汉大学中南医院 一种二聚化钆基t1磁共振对比造影剂及其制备方法和用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4622420A (en) 1980-03-18 1986-11-11 The Regents Of The University Of California Chelating agents and method
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
US4822594A (en) 1987-01-27 1989-04-18 Gibby Wendell A Contrast enhancing agents for magnetic resonance images
US5364613A (en) * 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
CA2071201A1 (en) 1989-12-11 1991-06-12 Ronald J. Mckinney Partially fluorinated compounds and polymers
US5162109A (en) * 1990-09-13 1992-11-10 Mallinckrodt Medical, Inc. Magnetic resonance imaging agents
US5562894A (en) * 1991-08-09 1996-10-08 Regents Of The University Of California Amino-acyl-type and catecholamine-type contrast agents for MRI
CA2115275A1 (en) * 1991-08-09 1993-02-18 David L. White Amino acid, ester and/or catechol contrast agents for mri
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
WO1994002068A1 (en) * 1992-07-21 1994-02-03 The General Hospital Corporation System of drug delivery to the lymphatic tissues
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images
ES2156143T3 (es) 1993-12-30 2001-06-16 Guerbet Sa Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas.
JPH07330773A (ja) 1994-06-07 1995-12-19 Toyo Hatsuka Kogyo Kk ポルフィリン誘導体とその用途
IT1283218B1 (it) 1996-03-08 1998-04-16 Bracco Spa Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi
IT1283651B1 (it) 1996-08-02 1998-04-23 Bracco Spa Chelati paramagnetici ad alta relassivita' in siero
GB9708265D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
DE19652387A1 (de) * 1996-12-04 1998-06-10 Schering Ag Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung
AU752812B2 (en) 1997-11-17 2002-10-03 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
IL145723A0 (en) * 2000-10-11 2002-07-25 Nihon Mediphysics Co Ltd Process for producing an amide compound
EP1369134A1 (de) * 2002-06-05 2003-12-10 Bracco Imaging S.p.A. Mittel fur magnetisches Bildformungsverfahren

Also Published As

Publication number Publication date
EP1509254A1 (de) 2005-03-02
WO2003103722A1 (en) 2003-12-18
US20100311962A1 (en) 2010-12-09
EP1509254B1 (de) 2009-01-14
JP4469273B2 (ja) 2010-05-26
DE60325849D1 (de) 2009-03-05
AU2003238192A1 (en) 2003-12-22
US8961927B2 (en) 2015-02-24
EP1369134A1 (de) 2003-12-10
US7780952B2 (en) 2010-08-24
US20050175543A1 (en) 2005-08-11
JP2005528453A (ja) 2005-09-22

Similar Documents

Publication Publication Date Title
ATE420664T1 (de) Mittel für magnetisches bildformungsverfahren
Wilson et al. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry
Moi et al. Stable bifunctional chelates of metals used in radiotherapy
Li et al. Development of an in vitro model for assessing the in vivo stability of lanthanide chelates
EP0533845A4 (en) Using 5,10,15,20-tetrakis(r-carboxyphenyl)porphine for detecting and treating lung cancer
DK0417870T3 (da) Chelatdannere til kompleksbinding af radioaktive isotoper, metalkomplekser deraf samt anvendelsen deraf til diagnostik og terapi
ATE195432T1 (de) Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel
Heller et al. Chemical speciation of trivalent actinides and lanthanides in biological fluids: the dominant in vitro binding form of curium (III) and europium (III) in human urine
La et al. Progress of coordination and utilization of zirconium-89 for positron emission tomography (PET) studies
Schmitthenner et al. Modular Synthesis of DOTA‐Metal‐Based PSMA‐Targeted Imaging Agents for MRI and PET of Prostate Cancer
Rasaneh et al. Synthesis and biodistribution studiesof 177Lu‐trastuzumab as a therapeutic agent in the breast cancer mice model
BR9508435A (pt) Quelentes macrocíclicos seus quelatos e usos dos mesmos no campo diagnóstico
DE59402379D1 (de) Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung als nmr- und röntgenkontrastmittel und verfahren zu deren herstellung
Grimanis et al. Provenance studies of Greek marbles by instrumental neutron activation analysis
Wardman et al. A probe for intracellular concentrations of drugs: delayed fluorescence from acridine orange
Vuk-Pavlović et al. The haem-environment in horseradish peroxidase as seen by proton magnetic relaxation
DK1154798T3 (da) Molekyler til behandling og diagnose af tumorer
Shachar-Hill et al. Measuring Nitrate in Plant Cells byin VivoNMR Using Gd3+ as a Shift Reagent
Schulz Conceptual models and computer models
Akselrod et al. Time-differential perturbed angular correlation studies of In-complexes used in nuclear medicine
LaBrecque Radioisotope induced X-ray emission (RIXE) studies in life sciences
Miller et al. Localized current field heating as an adjunct to radiation therapy
Milanov et al. A complex evaluation of the efficiency of 131 I-ablation in patients with differentiated thyroid carcinoma after surgery
Willnow et al. Effect of hyperthermia 42.5° C/120 min on 3H-thymidine incorporation in different tissue components of Wilms' tumors: An in vitro study
Meares Use of bifunctional chelating agents for radiolabeling antibodies

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties